Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK

BACKGROUND: SCCHN is the sixth most common cancer worldwide. Locally advanced SCCHN continues to be a therapeutic challenge with high rates of morbidity and mortality and a low cure rate. Despite the apparent impact of SCCHN on patients and presumably society, the economic burden of the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kun, Amonkar, Mayur M, Högberg, Daniel, Kasteng, Frida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219567/
https://www.ncbi.nlm.nih.gov/pubmed/22035422
http://dx.doi.org/10.1186/1758-3284-3-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219567/
https://www.ncbi.nlm.nih.gov/pubmed/22035422
http://dx.doi.org/10.1186/1758-3284-3-47

Ejemplares similares